Total Cholesterol: Ranges, High Results & What They Mean

The table shows common U.S. adult screening labels. It does not diagnose disease, define a treatment goal or apply to children. Laboratories can print slightly different boundaries, and a clinician may use a much lower LDL-C or non-HDL-C goal when cardiovascular risk is high.^{See reference 1,See reference 3,See reference 5}

The NHS gives below 5.0 mmol/L as a broad guide for a healthy adult and explicitly says the result must be combined with age, blood pressure, health conditions and other factors. That guide is not interchangeable with the U.S. 200 mg/dL boundary, which converts to 5.1720 mmol/L.^{See reference 6,See reference 11}

A result just below a traditional cutoff is not automatically safe, and one just above it is not an emergency. The distribution across LDL-C, HDL-C and other particles—and the person's exposure over time—matters more than the label alone.^{See reference 1,See reference 2,See reference 3}

A standard lipid panel usually reports total cholesterol, LDL-C, HDL-C and triglycerides. Total cholesterol does not tell you how the cholesterol is distributed, so two people with the same total can have different patterns and different risk.^{See reference 4,See reference 5,See reference 7}

Non-HDL-C is calculated as total cholesterol minus HDL-C. It captures cholesterol in LDL and other non-HDL particles, including triglyceride-rich remnants and Lp(a). Current 2026 U.S. guidance uses LDL-C and non-HDL-C goals, recommends measuring Lp(a) at least once in adulthood, and uses ApoB selectively to refine risk.^{See reference 1,See reference 2,See reference 7}

HDL-C contributes to the total number. A high HDL-C can therefore raise total cholesterol, but HDL is not a stand-alone treatment target and should not be used to dismiss elevated LDL-C, non-HDL-C or an inherited risk marker.^{See reference 2,See reference 3}

For total, LDL and HDL cholesterol, divide mg/dL by 38.67 to obtain mmol/L, or multiply mmol/L by 38.67 to obtain mg/dL. The forward multiplier is approximately 0.02586. Triglycerides use 88.57, so their factor must not be substituted.^{See reference 11}

The tools above round only the displayed answer. At a boundary, classify the original laboratory value and unit. For example, 200 mg/dL is 5.1720 mmol/L and 240 mg/dL is 6.2064 mmol/L, while a report rounded to one decimal may show 5.2 or 6.2 and hide which side of the exact boundary the raw result occupied.^{See reference 5,See reference 11}

Conversion does not turn one country's screening labels into another country's clinical guidance. Keep the laboratory's own reference information and use the converted value only for comparison or communication.^{See reference 3,See reference 5,See reference 6}

A high total commonly reflects higher LDL-C or other non-HDL cholesterol. Contributors can include inherited lipid disorders, a pattern high in saturated or trans fat, low physical activity, overweight or obesity, diabetes, hypothyroidism, chronic kidney disease, age, menopause and alcohol excess. More than one contributor can apply.^{See reference 5,See reference 8}

Some medicines can change the lipid profile, including certain beta-blockers, thiazide diuretics, amiodarone, steroids, retinoids, chemotherapy and immunosuppressants. The right response is a medicine review—not stopping treatment on your own.^{See reference 8}

High HDL-C can raise the total mathematically. That pattern still needs the full panel because a high HDL number does not establish that LDL-C, non-HDL-C, ApoB, Lp(a) or overall risk is low.^{See reference 2,See reference 3}

A single total cholesterol result cannot identify the cause. Review the trend, family history, LDL-C, HDL-C, triglycerides, non-HDL-C, relevant thyroid, glucose, kidney and liver context, pregnancy status and medicines with a qualified clinician.^{See reference 1,See reference 7,See reference 8}

A lower total cholesterol is often expected when LDL-C has improved through effective lifestyle or prescribed treatment. The total number alone does not show whether the change occurred in LDL-C, HDL-C or another fraction, so use the full panel.^{See reference 3,See reference 7,See reference 9}

An unexpectedly low untreated result can occur with hyperthyroidism, severe liver disease, malabsorption, malnutrition, some cancers or rare inherited disorders. A low total does not diagnose any of these conditions; the finding matters most when it is new, unexplained or accompanied by symptoms or other abnormal results.^{See reference 5}

Do not try to raise a low result with alcohol, saturated fat or supplements. Confirm the value and review the wider clinical picture when it is unexpected.^{See reference 5,See reference 14}

The 2026 AHA/ACC guideline uses PREVENT-ASCVD risk estimates for eligible primary-prevention decisions, restores risk-based LDL-C and non-HDL-C goals, recommends Lp(a) at least once in adulthood and uses ApoB or coronary artery calcium selectively. Total cholesterol helps the assessment but is not the treatment target on its own.^{See reference 1,See reference 2}

Across randomized statin trials, each 1.0 mmol/L (38.7 mg/dL) reduction in LDL-C produced about a one-fifth proportional reduction in major vascular events. That is an LDL-C treatment effect, not proof that lowering total cholesterol by the same amount gives the same outcome. Absolute benefit depends on starting risk and time.^{See reference 13}

Healthy habits remain valuable, but severe inherited LDL elevation often cannot be managed by lifestyle alone. Do not start, stop or replace a lipid-lowering medicine from an online range table or supplement claim.^{See reference 1,See reference 2,See reference 8,See reference 15,See reference 16}

Screening frequency depends on age, history and risk. AHA says all adults 19 and older should have a lipid panel, while NHLBI gives five-year screening as a general starting point for many younger adults and closer intervals with age or higher risk. Local guidance may differ.^{See reference 4,See reference 7}

Repeat sooner when a result is unexpected, very high, close to a decision boundary, obtained during acute illness or pregnancy, or follows a meaningful medicine or lifestyle change. Use similar conditions and the same laboratory when practical so the trend is easier to interpret.^{See reference 5,See reference 7,See reference 8}

The clinician's schedule should follow the component being treated and the decision being made. A repeated total without LDL-C, HDL-C and triglycerides usually answers less than a complete lipid panel.^{See reference 1,See reference 4,See reference 7}